Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Albiglutide

Albiglutide

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Albiglutide

13 trials tracked of Albiglutide: 10 in phase 3 or 4 and 2 with published results. The most-cited published study has 83 citations.

13Trials tracked
10Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 10 Phase 2 3
  1. Phase 3 Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period Completed · 83 cited
  2. Phase 3 Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus Completed · 68 cited
  3. Phase 3 A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus Completed
  4. Phase 3 Safety and Efficacy of Albiglutide in Type 2 Diabetes Completed
  5. Phase 3 A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. Completed
  6. Phase 3 Safety and Efficacy Study of Albiglutide in Type 2 Diabetes Completed
Show 7 more trials
  1. Phase 3 Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes Completed
  2. Phase 3 A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes Completed
  3. Phase 3 A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes Completed
  4. Phase 3 A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide. Completed
  5. Phase 2 Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes Completed
  6. Phase 2 Pharmacokinetics/Pharmacodynamics of Albiglutide Completed
  7. Phase 2 Dose Ranging Study of Albiglutide in Japanese Subjects Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
GLP-1 receptor agonists associated with favorable cardiovascular outcomes in adults with Type 2 Diabetes
Nutrition & Obesity Medicine Sys. Review
GLP-1 receptor agonists associated with favorable cardiovascular outcomes in adults with Type 2 Diabetes GLP-1 medications show heart benefits for people with Type 2 Diabetes
This meta-analysis of randomized controlled trials included 97,173 adults with Type 2 diabetes to evaluate GLP-1-based therapies. The analys…
A large review of clinical trials shows that GLP-1 therapies can reduce major heart events and deaths in adults with Type 2 diabetes.
Aug 7, 2026
GLP-1 RA exposure in early pregnancy not significantly tied to hypertensive disorders
Diabetes & Endocrinology Meta-analysis
GLP-1 RA exposure in early pregnancy not significantly tied to hypertensive disorders GLP-1 Medications Show No Link to Pregnancy Hypertension Risk
This meta-analysis of observational cohort studies assessed the risk of hypertensive disorders of pregnancy (HDP) after periconceptional or …
A large review of over 10,000 pregnancies suggests that GLP-1 medications may not increase the risk of high blood pressure during pregnancy.
Aug 1, 2026